Serum anti-Mullerian hormone levels correlate with ovarian response in idiopathic hypogonadotropic hypogonadism

Journal of Assisted Reproduction and Genetics

Volumn 29, Issue 7, 2012, Pages 597-602

  Sonmezer M ^a   Ozmen B ^a   Atabekoglu, C S ^a   Papuccu, E G ^a   Ozkavukcu, S ^a   Berker, B ^a   Pabuccu, R ^b  

^a ANKARA UNIVERSITY   (Turkey)

^b UFUK UNIVERSITY   (Turkey)

Author keywords

Anti Mullerian hormone; Hypogonadotropic hypogonadism; IVF outcome; Ovarian reserve; Ovarian response

Indexed keywords

ESTRADIOL; HUMAN MENOPAUSAL GONADOTROPIN; LOW DOSE ORAL CONTRACEPTIVE; MUELLERIAN INHIBITING FACTOR; PROGESTERONE;

ADULT; ARTICLE; CLINICAL ARTICLE; DISEASE ASSOCIATION; EMBRYO TRANSFER; FEMALE; FERTILIZATION IN VITRO; HORMONE BLOOD LEVEL; HUMAN; HYPOGONADOTROPIC HYPOGONADISM; IDIOPATHIC DISEASE; MENSTRUAL CYCLE; OOCYTE; OVARY FUNCTION; OVARY HYPERSTIMULATION; PREGNANCY RATE; PRIORITY JOURNAL; PROSPECTIVE STUDY; TREATMENT OUTCOME;

EID: 84864912170     PISSN: 10580468     EISSN: 15737330     Source Type: Journal    
DOI: 10.1007/s10815-012-9759-1     Document Type: Article

References (26)

1. Arbo E, Vetori DV, Jimenez MF, Freitas FM, Lemos N, Cunha- Filho JS. Serum anti-mullerian hormone levels and follicular cohort characteristics after pituitary suppression in the late luteal phase with oral contraceptive pills. Hum Reprod. 2007;22 (12):3192-6.
2. Baarends WM, Uilenbroek JT, Kramer P, Hoogerbrugge JW, van Leeuwen EC, Themmen AP, et al. Anti-müllerian hormone and anti-müllerian hormone type II receptor messenger ribonucleic acid expression in rat ovaries during postnatal development, the estrous cycle, and gonadotropin-induced follicle growth. Endocrinology. 1995;136:4951-62.
3. Broer SL, Dolleman M, Opmeer BC, Fauser BC, Mol BW, Broekmans FJ. AMH and AFC as predictors of excessive response in controlled ovarian hyperstimulation: a meta analysis. Hum Reprod Update. 2011;17(1):46-54.
4. Burgués S, Spanish Collaborative Group on Female Hypogonadotrophic Hypogonadism. The effectiveness and safety of recombinant human LH to support follicular development induced by recombinant human FSH in WHO group I anovulation: evidence from a multicentre study in Spain. Hum Reprod. 2001;16 (12):2525-32.
5. Fisch JD, Rodriguez H, Ross R, Overby G, Sher G. The Graduated Embryo Score (GES) predicts blastocyst formation and pregnancy rate fromcleavage-stage embryos.Hum Reprod. 2001;16(9):1970-5.
6. Hehenkamp WJ, Looman CW, Themmen AP, de Jong FH, Te Velde ER, Broekmans FJ. Anti-Mullerian hormone levels in the spontaneous menstrual cycle do not show substantial fluctuation. J Clin Endocrinol Metab. 2006;91:4057-63.
7. La Marca A, Pati M, Orvieto R, Stabile G, Carducci Artenisio A, et al. Serum Anti-Mullerian Hormone levels in women with secondary amenorrhea. Fertil Steril. 2006;85:1547-9.
8. La Marca A, Sighinolfi G, Radi D, Argento C, Baraldi E, Carducci A, et al. Anti-Müllerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART). Hum Reprod. 2009;16(2):113-30.
9. Levy T, Orvieto R, Homburg R, Peleg D, Dekel A, Ben-Rafael Z. Severe ovarian hyperstimulation syndrome despite low plasma oestrogen concentrations in a hypogonadotrophic, hypogonadal patient. Hum Reprod. 1996;11(6):1177-9.
10. Luisi S, Ciani V, Podfigurna-Stopa A, et al. Serum anti-Müllerian hormone, inhibin B, and total inhibin levels in women with hypothalamic amenorrhea and anorexia nervosa. Gynecol Endocrinol. 2012;28(1):34-8.
11. Majumder K, Gelbaya TA, Laing I, Nardo LG. The use of anti- Müllerian hormone and antral follicle count to predict the potential of oocytes and embryos. Eur J Obstet Gynecol Reprod Biol. 2010;150(2):166-70.
12. Nakhuda GS, Douglas NC, Thornton MH, Guarnaccia MM, Lobo R, Sauer MV. Anti-Müllerian hormone testing is useful for individualization of stimulation protocols in oocyte donors. Reprod Biomed Online. 2010;20(1):42-7.
13. Nardo LG, Gelbaya TA, Wilkinson H, Roberts SA, Yates A, Pemberton P, et al. Circulating basal anti-Müllerian hormone levels as predictor of ovarian response in women undergoing ovarian stimulation for in vitro fertilization. Fertil Steril. 2009;92:1586-93.
14. Nelson SM, Yates RW, Lyall H, Jamieson M, Traynor I, Gaudoin M, et al. Anti-Müllerian hormone-based approach to controlled ovarian stimulation for assisted conception. Hum Reprod. 2009;24(4):867-75.
15. Panidis D, Georgopoulos NA, Piouka A, Katsikis I, Saltamavros AD, Decavalas G, et al. The impact of oral contraceptives and metformin on anti-Müllerian hormone serum levels in women with polycystic ovary syndrome and biochemical hyperandrogenemia. Gynecol Endocrinol. 2010 Sep 14, [Epub ahead of print]. 16.
16. Riggs R, Kimble T, Oehninger S, Bocca S, Zhao Y, Leader B, et al. Anti-Müllerian hormone serum levels predict response to controlled ovarian hyperstimulation but not embryo quality or pregnancy outcome in oocyte donation. Fertil Steril. 2011;95:410-2.
17. Rothman MS, Wierman ME. Female hypogonadism: evaluation of the hypothalamic-pituitary-ovarian axis. Pituitary. 2008;11:163-9.
18. Somunkiran A, Yavuz T, Yucel O, Ozdemir I. Anti-Müllerian hormone levels during hormonal contraception in women with polycystic ovary syndrome. Eur J Obstet Gynecol Reprod Biol. 2007;134:196-201.
19. Speroff L, Fritz MA. Chapter 32, induction of ovulation. In: Speroff L, Fritz MA, editors. Clinical gynecologic endocrinology and infertility. 7th ed. Philadelphia: Lippincott Williams & Wilkins; 2005. p. 1293-331.
20. Speroff L, Fritz MA. Chapter 11, amenorrhea. In: Speroff L, Fritz MA, editors. Clinical gynecologic endocrinology and infertility. 8th ed. Philadelphia: Lippincott Williams & Wilkins; 2011. p. 443.
21. Steiner AZ, Stanczyk FZ, Patel S, Edelman A. Antimullerian hormone and obesity: insights in oral contraceptive users. Contraception. 2010;81(3):245-8.
22. Streuli I, Fraisse T, Pillet C, Ibecheole V, Bischof P, de Ziegler D. Serum antimüllerian hormone levels remain stable throughout the menstrual cycle and after oral or vaginal administration of synthetic sex steroids. Fertil Steril. 2008;90(2):395-400.
23. Sungurtekin U, Fraser IS, Shearman RP. Pregnancy in women with Kallmann's Syndrome. Fertil Steril. 1995;63(3):494-9.
24. Tran ND, Cedars MI, Rosen MP. The role of anti-müllerian hormone (AMH) in assessing ovarian reserve. J Clin Endocrinol Metab. 2011;96(12):3609-14.
25. Ulug U, Ben-Shlomo I, Tosun S, Erden HF, Akman MA, Bahceci M. The reproductive performance of women with hypogonadotropic hypogonadism in an in- vitro fertilization and embryo transfer program. J Assist Reprod Genet. 2005;22(4):167-71.
26. Weenen C, Laven JS, Von Bergh AR, Cranfield M, Groom NP, Visser JA, et al. Anti-Müllerian hormone expression pattern in the human ovary: potential implications for initial and cyclic follicle recruitment. Mol Hum Reprod. 2004;10(2):77-83.